Aspect Partners »

Dyne Therapeutics shares owned by Aspect Partners

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Aspect Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.6k 725 13.30

More positions owned by Aspect Partners

Spdr S&p 500 Etf Trust Etf (SPY)
Ishares U.s. Real Estate Etf Etf (IYR)
Ishares Msci Eafe Etf Etf (EFA)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Core International Aggregate Bond Etf Etf (IAGG)
Real Estate Select Sector Spdr Fund Etf (XLRE)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Ishares Core S&p Small Cap Etf Etf (IJR)
Vanguard International Dividend Appreciation Etf Etf (VIGI)
Spdr Gold Shares Etf (GLD)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Vaneck Gold Miners Etf Etf (GDX)

View all positions for Aspect Partners

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
Citadel Advisors
Vanguard Group
VR Adviser
Franklin Resources
Logos Global Management
Vivo Capital
Artal Group
Jennison Associates
Frazier Life Sciences Management
Goldman Sachs Group
Ikarian Capital
Commodore Capital
Dimensional Fund Advisors

View all funds holding Dyne Therapeutics